The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Incidence of hyperthyroidism in Sweden
Abstract
Introduction: The incidence of hyperthyroidism has been reported in various countries to be 23–93/100 000 inhabitants per year. This extended study has evaluated the incidence for ∼40% of the Swedish population of 9 million inhabitants. Sweden is considered to be iodine sufficient country. Methods: All patients including children, who were newly diagnosed with overt hyperthyroidism in the years 2003–2005, were prospectively registered in a multicenter study. The inclusion criteria are as follows: clinical symptoms and/or signs of hyperthyroidism with plasma TSH concentration below 0.2 mIE/l and increased plasma levels of free/total triiodothyronine and/or free/total thyroxine. Patients with relapse of hyperthyroidism or thyroiditis were not included. The diagnosis of Graves' disease (GD), toxic multinodular goiter (TMNG) and solitary toxic adenoma (STA), smoking, initial treatment, occurrence of thyroid-associated eye symptoms/signs, and demographic data were registered. Results: A total of 2916 patients were diagnosed with de novo hyperthyroidism showing the total incidence of 27.6/100 000 inhabitants per year. The incidence of GD was 21.0/100 000 and toxic nodular goiter (TNG=STA+TMNG) occurred in 692 patients, corresponding to an annual incidence of 6.5/100 000. The incidence was higher in women compared with men (4.2:1). Seventy-five percent of the patients were diagnosed with GD, in whom thyroid-associated eye symptoms/signs occurred during diagnosis in every fifth patient. Geographical differences were observed. Conclusion: The incidence of hyperthyroidism in Sweden is in a lower range compared with international reports. Seventy-five percent of patients with hyperthyroidism had GD and 20% of them had thyroid-associated eye symptoms/signs during diagnosis. The observed geographical differences require further studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, toxic nodular goiter may actually be more common than GD in older patients, especially in regions of iodine deficiency (13,14).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [14]
In the citing paper
“Although toxic nodular goiter is less common than GD, its prevalence increases with age and in the presence of dietary iodine deficiency.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [14]
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Weetman, A. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431707 · Cited by 828
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Bartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A. K., Kendall‐Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K. G., Boschi, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0666 · Cited by 805
Iodine intake as a determinant of thyroid disorders in populations
Laurberg, P., Cerqueira, C., Ovesen, L., Rasmussen, L. B., Perrild, H., Andersen, S., Pedersen, I. B., & Carlé, A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.013 · Cited by 507
Bartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0315 · Cited by 406
Cooper, D. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14073-1 · Cited by 384
Research works printed but not linked: 1
- Buchinger, 2000, Acta medica Austriaca, 27, 51, 10.1046/j.1563-2571.2000.00206.x · DOI
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“Therefore, toxic nodular goiter may actually be more common than GD in older patients, especially in regions of iodine deficiency (13,14).”
BackgroundBartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G. J., Marcocci, C., Perros, P., Salvi, M., & Wiersinga, W. M. (2016) · European Thyroid Journal · doi:10.1159/000443828 · Cited by 943
De Leo, S., Lee, S. Y., & Braverman, L. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00278-6 · Cited by 883
The incidence and prevalence of thyroid autoimmunity
McLeod, D. S. A., & Cooper, D. S. (2012) · Endocrine · doi:10.1007/s12020-012-9703-2 · Cited by 613
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro‐Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 421
Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
Bartalena, L., Piantanida, E., Gallo, D., Lai, A., & Tanda, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615993 · Cited by 386
Tanda, M. L., Piantanida, E., Liparulo, L., Veronesi, G., Lai, A., Sassi, L., Pariani, N., Gallo, D., Azzolini, C., Ferrario, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3873 · Cited by 328
Cooper, D. S., & Laurberg, P. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70086-x · Cited by 310
Diagnosis and classification of Graves' disease
Menconi, F., Marcocci, C., & Marinò, M. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.013 · Cited by 285
Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
Antonelli, A., Ferrari, S. M., Ragusa, F., Elia, G., Paparo, S. R., Ruffilli, I., Patrizio, A., Giusti, C., Gonnella, D., Cristaudo, A., et al. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2020.101387 · Cited by 270
Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review
Chin, Y. H., Ng, C. H., Lee, M. H., Koh, J. W. H., Kiew, J. J., Yang, S. P., Sundar, G., & Khoo, C. M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14296 · Cited by 226
Current concepts regarding Graves’ orbitopathy
Bartalena, L., & Tanda, M. L. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13524 · Cited by 215
Graves' Ophthalmopathy: Epidemiology and Natural History
Hiromatsu, Y., Eguchi, H., Tani, J., Kasaoka, M., & Teshima, Y. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1518 · Cited by 193
Perros, P., Hegedűs, L. D., Bartalena, L., Marcocci, C., Kahaly, G. J., Baldeschi, L., Salvi, M., Lazarus, J. H., Eckstein, A. K., Pitz, S., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0625-1 · Cited by 171
Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
Wiersinga, W. M. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30046-8 · Cited by 167
Role of genetic and non-genetic factors in the etiology of Graves’ disease
Marinò, M., Latrofa, F., Menconi, F., Chiovato, L., & Vitti, P. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0214-2 · Cited by 141
Nyström, H. F., Jansson, S. K. G., & Berg, G. E. B. (2013) · Clinical Endocrinology · doi:10.1111/cen.12060 · Cited by 135
Self-citationLaurberg, P., Berman, D. C., Bülow Pedersen, I., Andersen, S., & Carlé, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1275 · Cited by 133
Graves’ disease: Introduction, epidemiology, endogenous and environmental pathogenic factors
Wémeau, J.-L., Klein, M., Sadoul, J., Briet, C., & Vélayoudom‐Céphise, F. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.09.002 · Cited by 134
Saeed, P., Rad, S. T., & Bisschop, P. H. L. T. (2018) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001146 · Cited by 131
Iodine status in the Nordic countries – past and present
Nyström, H. F., Brantsæter, A. L., Erlund, I., Gunnarsdóttir, I., Hulthén, L., Laurberg, P., Mattisson, I., Rasmussen, L. B., Virtanen, S. M., & Meltzer, H. M. (2016) · Food & Nutrition Research · doi:10.3402/fnr.v60.31969 · Cited by 132
Self-citation2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
Mooij, C. F., Cheetham, T. D., Verburg, F. A., Eckstein, A., Pearce, S. H., Léger, J., & van Trotsenburg, A. S. P. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0073 · Cited by 152
Prevalence and natural history of Graves' orbitopathy in the XXI century.
Piantanida, E., Tanda, M. L., Lai, A., Sassi, L., & Bartalena, L. (2013) · PubMed · doi:10.3275/8937 · Cited by 120
Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study
Wang, M., Lee, W., Huang, T., Chu, C., & Hsieh, C. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12336 · Cited by 114
Brito, J. P., Payne, S. R., Ospina, N. S., Rodríguez‐Gutiérrez, R., Maraka, S., Sangaralingham, L. R., Iñiguez‐Ariza, N. M., Montori, V. M., & Stan, M. N. (2020) · Thyroid · doi:10.1089/thy.2019.0132 · Cited by 110
Wiersinga, W. M., Eckstein, A. K., & Žarković, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00066-x · Cited by 132
Thyrotoxicosis: Diagnosis and Management
Sharma, A. R., & Stan, M. N. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.011 · Cited by 116
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism
Sjölin, G., Holmberg, M., Törring, O., Byström, K., Khamisi, S., de Laval, D., Abraham‐Nordling, M., Calissendorff, J., Lantz, M., Hallengren, B., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0085 · Cited by 112
Self-citationTörring, O., Watt, T., Sjölin, G., Byström, K., Abraham‐Nordling, M., Calissendorff, J., Cramon, P. K., Nyström, H. F., Hallengren, B., Holmberg, M., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0315 · Cited by 107
Self-citationTeprotumumab for the treatment of chronic thyroid eye disease
Ugradar, S., Kang, J. Y., Kossler, A. L., Zimmerman, E., Braun, J., Harrison, A. R., Bose, S., Cockerham, K. P., & Douglas, R. S. (2021) · Eye · doi:10.1038/s41433-021-01593-z · Cited by 100
Politi, L. S., Godi, C., Cammarata, G., Ambrosi, A., Iadanza, A., Lanzi, R., Falini, A., & Marzoli, S. B. (2014) · European Radiology · doi:10.1007/s00330-014-3103-3 · Cited by 97
Frank, C., Braeth, S., Dietrich, J. W., Wanjura, D., & Loos, U. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1554662 · Cited by 70
Mohlin, E., Nyström, H. F., & Eliasson, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0811 · Cited by 69
Self-citationLéger, J., Petit, I., Rodrigue, D., Lambert, A.-S., & Coutant, R. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.08.001 · Cited by 70
Calissendorff, J., Mikulski, E., Larsen, E. H., & Möller, M. C. (2015) · European Thyroid Journal · doi:10.1159/000381768 · Cited by 70
Self-citationCalissendorff, J., & Falhammar, H. (2017) · Endocrine · doi:10.1007/s12020-017-1461-8 · Cited by 67
Self-citationLéger, J., Kaguelidou, F., Alberti, C., & Carel, J. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.008 · Cited by 65
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors
Bartalena, L., Gallo, D., Tanda, M. L., & Kahaly, G. J. (2023) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000002467 · Cited by 73
Li, Q., Ye, H., Ding, Y., Chen, G., Liu, Z., Xu, J., Chen, R., & Yang, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176064 · Cited by 64
Boboridis, K. G., Uddin, J. M., Mikropoulos, D. G., Bunce, C., Mangouritsas, G., Voudouragkaki, I. C., & Konstas, A. G. P. (2015) · Advances in Therapy · doi:10.1007/s12325-015-0228-y · Cited by 61
Race/Ethnicity and the Prevalence of Thyrotoxicosis in Young Americans
McLeod, D. S. A., Cooper, D. S., Ladenson, P. W., Whiteman, D. C., & Jordan, S. J. (2015) · Thyroid · doi:10.1089/thy.2014.0504 · Cited by 58
Léger, J., & Carel, J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0938 · Cited by 57
Diagnosis and management of hyperthyroidism from prenatal life to adolescence
Léger, J., & Carel, J. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.03.014 · Cited by 57
The thyroid, the eyes and the gut: a possible connection
Covelli, D., & Ludgate, M. E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0594-6 · Cited by 53
Epidemiology of Childhood Hyperthyroidism in France: A Nationwide Population-Based Study
Simon, M. E., Rigou, A., Moal, J. L., Zeghnoun, A., Tertre, A. L., de Crouy-Chanel, P., Kaguelidou, F., & Léger, J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00273 · Cited by 48
Schuh, A., Ayvaz, G., Baldeschi, L., Baretić, M., Bechtold, D., Boschi, A., Brix, T. H., Burlacu, M., Ćirić, J., Covelli, D., et al. (2023) · British Journal of Ophthalmology · doi:10.1136/bjo-2022-322442 · Cited by 49
Jónsdóttir, B., Larsson, C., Carlsson, A., Forsander, G., Ivarsson, S. A., Lernmark, Å., Ludvigsson, J., Marcus, C., Samuelsson, U., Örtqvist, E., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2335 · Cited by 47
Roos, J. C. P., Paulpandian, V., & Murthy, R. (2018) · Eye · doi:10.1038/s41433-018-0242-9 · Cited by 47
Oeverhaus, M., Winkler, L., Stähr, K., Daser, A., Bechrakis, N. E., Stöhr, M., Chen, Y., & Eckstein, A. K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1160172 · Cited by 48
Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study
Andersen, S. L., Lönn, S., Vestergaard, P., & Törring, O. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0314 · Cited by 44
Self-citationComparative proteomic analysis of tear fluid in Graves' disease with and without orbitopathy
Aass, C., Norheim, I., Eriksen, E. F., Børnick, E. C., Thorsby, P. M., & Pepaj, M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13122 · Cited by 42
Choi, W. S., Li, Y., Ji, Y. S., & Yoon, K. C. (2018) · BMC Ophthalmology · doi:10.1186/s12886-018-0969-x · Cited by 41
Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management
Yu, C., Ford, R. L., Wester, S. T., & Shriver, E. M. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3217_21 · Cited by 40
Hyperthyroidism Prevalence in China After Universal Salt Iodization
Wang, C., Li, Y., Teng, D., Shi, X., Ba, J., Chen, B., Du, J., He, L., Lai, X., Li, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651534 · Cited by 40
Korevaar, T. I. M., Leung, A. M., Alexander, E. K., Bliddal, S., Boelaert, K., Brenta, G., Chou, R., Dhillon‐Smith, R. K., Dosiou, C., Eaton, J. L., et al. (2026) · Thyroid · doi:10.1177/10507256261445624 · Cited by 47
Deep learning-based image analysis of eyelid morphology in thyroid-associated ophthalmopathy
Shao, J., Huang, X., Gao, T., Cao, J., Wang, Y., Zhang, Q., Lou, L., & Ye, J. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-551 · Cited by 38
Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model
Schlüter, A., Flögel, U., Díaz‐Cano, S. J., Görtz, G.-E., Stähr, K., Oeverhaus, M., Philipp, S., Mattheis, S., Moeller, L. C., Lang, S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31253-4 · Cited by 38
Autilio, C., Morelli, R., Locantore, P., Pontecorvi, A., Zuppi, C., & Carrozza, C. (2017) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563217700655 · Cited by 37
Thomsen, H., Li, X., Sundquist, K., Sundquist, J., Försti, A., & Hemminki, K. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100058 · Cited by 40
Update on the surgical management of Graves’ orbitopathy
Baeg, J. Y., Choi, H. S., Kim, C., Kim, H., & Jang, S. Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1080204 · Cited by 36
The Incidence of Childhood Thyrotoxicosis Is Increasing in Both Girls and Boys in Sweden
Rodanaki, M., Lodefalk, M., Forssell, K., Arvidsson, C., Forssberg, M., & Åman, J. (2019) · Hormone Research in Paediatrics · doi:10.1159/000500265 · Cited by 36
Bano, A., Gan, E. H., Addison, C., Narayanan, K., Weaver, J. U., Tsatlidis, V., & Razvi, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01738 · Cited by 34
Asymmetric Graves’ Orbitopathy
Panagiotou, G., & Perros, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.611845 · Cited by 36
Lee, H. J., Lombardi, A., Stefan, M., Li, C. W., Inabnet, W. B., Owen, R. P., Concepcion, E., & Tomer, Y. (2016) · Endocrinology · doi:10.1210/en.2016-1609 · Cited by 34
Wang, Y., Tooley, A. A., Mehta, V. J., Garrity, J. A., Harrison, A. R., & Mettu, P. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000219 · Cited by 33
Wang, J., & Lan, Q. (2016) · British Journal of Radiology · doi:10.1259/bjr.20160418 · Cited by 34
Thyroid disorders in pregnancy
Yalamanchi, S., & Cooper, D. S. (2015) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000226 · Cited by 36
Potvin, A. R. G. G., Pakdel, F., & Saeed, P. (2023) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000002555 · Cited by 32
Boulakh, L., Nygaard, B., Bek, T., Faber, J. O., Heegaard, S., Toft, P. B., Poulsen, H. E., Toft‐Petersen, A. P., Hesgaard, H. B., & Ellervik, C. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.1002 · Cited by 31
Evaluating thyroid function in pregnant women
Geno, K. A., & Nerenz, R. D. (2022) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2022.2050182 · Cited by 31
Veltri, F., Rocha, F. O., Willems, D., Praet, J., Grabczan, L., Kleynen, P., Pepersack, T., & Poppe, K. G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.008 · Cited by 29
Iacobæus, L., & Sahlin, S. (2016) · Orbit · doi:10.1080/01676830.2016.1176049 · Cited by 28
Jarušaitienė, D., Verkauskienė, R., Jašinskas, V., & Jankauskienė, J. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8129497 · Cited by 28
Increased incidence of Graves' disease during the SARS‐CoV2 pandemic
Galindo, D. E. B., Bachiller, B. R., Roza, L. G., de Morales, J. M. G. R., Lasheras, F. S., Arnáiz, E. G., Cobo, D. A., Ballesteros-Pomar, M. D., & Rodríguez, I. C. (2022) · Clinical Endocrinology · doi:10.1111/cen.14860 · Cited by 28
Novel Thermal Imaging Analysis Technique for Detecting Inflammation in Thyroid Eye Disease
Maria, C. D., Allen, J., Dickinson, J., Neoh, C., & Perros, P. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1957 · Cited by 28
Giesecke, P., Frykman, V., Wallin, G., Lönn, S., Discacciati, A., Törring, O., & Rosenqvist, M. A. (2017) · British journal of surgery · doi:10.1002/bjs.10665 · Cited by 28
Self-citationSmith, T. J., & Bartalena, L. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0389 · Cited by 27
Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy
Caputo, M., Pecere, A., Sarro, A., Mele, C., Ucciero, A., Pagano, L., Prodam, F., Aimaretti, G., Marzullo, P., & Barone‐Adesi, F. (2020) · Endocrine · doi:10.1007/s12020-020-02222-7 · Cited by 27
Skov, J., Calissendorff, J., Eriksson, D., Magnusson, P., Kämpe, O., Bensing, S., & Kuja-Halkola, R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa956 · Cited by 25
Self-citationGraves’ Disease in Children: An Update
Metwalley, K. A., & Farghaly, H. S. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514221150615 · Cited by 29
Patient Knowledge of Antithyroid Drug-Induced Agranulocytosis
Robinson, J., Richardson, M., Hickey, J., James, A., Pearce, S. H. S., Ball, S. G., Quinton, R., Morris, M., Miller, M. A., & Perros, P. (2014) · European Thyroid Journal · doi:10.1159/000367990 · Cited by 25
Zhang, Y., Li, X., Guo, C., Dong, J., & Liao, L. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03022-2 · Cited by 23
Medghalchi, A., Akbari, M., Alizadeh, Y., & Moghadam, R. S. (2018) · Journal of Current Ophthalmology · doi:10.1016/j.joco.2018.07.001 · Cited by 22
Molecular Biomarkers in Thyroid Eye Disease: A Literature Review
Ueland, H. O., Neset, M. T., Methlie, P., Ueland, G. Å., Pakdel, F., & Rødahl, E. (2023) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000002466 · Cited by 26
Independent Pretreatment Predictors of Graves’ Disease Outcome
Daukšienė, D., Daukša, A., & Mickuvienė, N. (2013) · Medicina · doi:10.3390/medicina49100067 · Cited by 21
Aass, C., Norheim, I., Eriksen, E. F., Børnick, E. C., Thorsby, P. M., & Pepaj, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175274 · Cited by 21
Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit
Mellington, F. E., Dayan, C. M., Dickinson, A. J., Hickey, J. L., MacEwen, C. J., McLaren, J., Perros, P., Rose, G. E., Uddin, J. M., Vaidya, B., et al. (2017) · Orbit · doi:10.1080/01676830.2017.1280057 · Cited by 21
Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab
Ugradar, S., Zimmerman, E., Parunakian, E., Kang, J. Y., Cockerham, K. P., & Douglas, R. S. (2023) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14208 · Cited by 19
Mammen, J. S. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.008 · Cited by 20
Prevalence, Incidence, and Clinical Characteristics of Thyroid Eye Disease in Japan
Watanabe, N., Kozaki, A., Inoue, K., Narimatsu, H., Shinohara, M., & LoPresti, M. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad148 · Cited by 19
Holmberg, M. O., Malmgren, H., Berglund, P., Käll, L. B., Heckemann, R. A., Johansson, B., Klasson, N., Olsson, E., Skau, S., & Nyström, H. F. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031168 · Cited by 19
Self-citationThyroid disorders in elderly: A comprehensive review
Thiruvengadam, S., & Luthra, P. (2021) · Disease-a-Month · doi:10.1016/j.disamonth.2021.101223 · Cited by 20
Long-term outcomes of graves disease in children treated with anti-thyroid drugs
Chiang, Y.-T., Ting, W., Huang, C., Huang, S.-K., Chan, C.-I., Cheng, B.-W., Lin, C., Wu, Y., Hung, C.-M., Li, H., et al. (2020) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2019.12.009 · Cited by 18
Triiodothyronine-predominant Graves' disease in childhood: detection and therapeutic implications
Harvengt, J., Boizeau, P., Chevenne, D., Zénaty, D., Paulsen, A., Simon, D., Guilmin‐Crépon, S., Alberti, C., Carel, J., & Léger, J. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0959 · Cited by 18
Mobarrez, F., Abraham‐Nordling, M., Aguilera‐Gatica, K., Friberg, I., Antovič, A., Pisetsky, D. S., Jörneskog, G., & Wallén, H. (2015) · Clinical Endocrinology · doi:10.1111/cen.12872 · Cited by 18
Self-citationPsychiatric complications in Graves’ disease
Holmberg, M., Malmgren, H., Berglund, P. F., Johansson, B., & Nyström, H. F. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0247 · Cited by 20
Self-citationBayramoğlu, E., Elmaoğulları, S., Sağsak, E., & Aycan, Z. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0495 · Cited by 17
Defective Regulatory B Cells Are Associated With Thyroid-Associated Ophthalmopathy
Guo, C. Y., Ding, Y., Li, Q., Li, Y., Wen, X., Ji, X., Bi, S., Chen, J., Xu, J., Chen, R., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01812 · Cited by 17
Decreased SIRT1 expression in the peripheral blood of patients with Graves’ disease
Yin, Q., Shen, L., Qi, Y., Song, D., Ye, L., Peng, Y. H., Wang, Y., Zhou, J., Ning, G., Wang, W., et al. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0501 · Cited by 17
Disorders of the thyroid in the newborn and infant
Vliet, G. V., & Deladoëy, J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00016-0 · Cited by 16
Metadata
- Authors
- Abraham-Nordling, M., Byström, K., Törring, O., Lantz, M., Berg, G., Calissendorff, J., Nyström, H. F., Jansson, S., Jörneskog, G., Karlsson, F. A., Nyström, E., Ohrling, H., Örn, T., Hallengren, B., & Wallin, G.
- Affiliations
- Örebro University (SE)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
- University of Gothenburg (SE)
- Sahlgrenska University Hospital (SE)
- Danderyds sjukhus (SE)
- Uppsala University (SE)
- Blekingesjukhuset (SE)
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12
- Volume
- 165
- Issue
- 6
- Pages
- 899-905
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2059024872
- Cited by
- 251
- References
- 39
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 24 · 2023: 20 · 2022: 27 · 2021: 17 · 2020: 26 · 2019: 12 · 2018: 19 · 2017: 15 · 2016: 17 · 2015: 11 · 2014: 14 · 2013: 7 · 2012: 4
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- hyperthyroidism, incidence, Graves' disease, toxic multinodular goiter, sex differences, regional variation, Sweden
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Hyperthyroidism, Male, Middle Aged, Prospective Studies, Registries, Sweden, Incidence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
